Novo Nordisk, H1 partner on AI for drug discovery, clinical trials

AI Funding & IPOs (Google News)August 4, 2026en

AI Funding & IPOs (Google News)

AI Global Wire

Provider-focused data company H1 announced a partnership with Novo Nordisk to develop AI models that help with the pharma giant's drug discovery efforts and clinical trial operations. New York-based ...

This is a short summary published by AI Global Wire. The full article is owned and hosted by AI Funding & IPOs (Google News) — open it there to read it in full.